Cargando…

Prevalence of iatrogenic atrial septal defects (iASD) after mitral valve (MV) transcatheter edge-to-edge repair (TEER) in the long-term follow-up

OBJECTIVES: To investigate prevalence of iatrogenic atrial septal defects (iASDs) after mitral valve (MV) transcatheter edge-to-edge repair (TEER) with the MitraClip in the long-term follow-up. BACKGROUND: MV TEER requires transseptal puncture using a large 22 F sheath. Prevalence, impact and haemod...

Descripción completa

Detalles Bibliográficos
Autores principales: Paukovitsch, Michael, Schneider, Leonhard Moritz, Reichart, Christine, Nita, Nicoleta, Rottbauer, Wolfgang, Keßler, Mirjam, Markovic, Sinisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8549666/
https://www.ncbi.nlm.nih.gov/pubmed/34702777
http://dx.doi.org/10.1136/openhrt-2021-001732
_version_ 1784590816077938688
author Paukovitsch, Michael
Schneider, Leonhard Moritz
Reichart, Christine
Nita, Nicoleta
Rottbauer, Wolfgang
Keßler, Mirjam
Markovic, Sinisa
author_facet Paukovitsch, Michael
Schneider, Leonhard Moritz
Reichart, Christine
Nita, Nicoleta
Rottbauer, Wolfgang
Keßler, Mirjam
Markovic, Sinisa
author_sort Paukovitsch, Michael
collection PubMed
description OBJECTIVES: To investigate prevalence of iatrogenic atrial septal defects (iASDs) after mitral valve (MV) transcatheter edge-to-edge repair (TEER) with the MitraClip in the long-term follow-up. BACKGROUND: MV TEER requires transseptal puncture using a large 22 F sheath. Prevalence, impact and haemodynamic effects of these iASDs remain unknown in the long-term follow-up. METHODS: This prospective study enrolled patients who had undergone first-time TEER at our university hospital between January 2017 and June 2018 for a clinical long-term follow-up study. Prevalence of iASD was investigated 12 months post-TEER using transoesophageal echocardiography (TEE). Study protocol further consisted of transthoracic echocardiography (TTE) and exercise testing. Incidence of all-cause death was compared 12 months post-TEE follow-up. This study was approved by local ethics committee. RESULTS: 48 patients participated in clinical follow-up examinations. Median time between TEER and clinical follow-up examination (TEE, TTE, exercise testing) was 19.5 (IQR: 7.0) months after TEER. Persistent iASD was found in 41.7% of patients. TEER was found to be equally effective in reducing MR and clinical symptoms in both groups at baseline as well as follow-up. Procedural fluoroscopy and device times were significantly longer in the iASD group. MR reduction and functional status (New York Heart Association Class, 6 Minute Walking Test distance) were similar in both groups. Nevertheless, a significant decrease in systolic pulmonary artery pressure (sPAP) and significantly smaller atrial diameters were observed in patients with iASD at follow-up. CONCLUSION: Prevalence of iASDs after TEER in long-term follow-up was about 41%. Although a significant reduction of sPAP and better left atrial reverse remodelling were accomplished in patients with iASD, clinical impact appears low. Manipulation at the atrial septum might play a key role in creating persisting iASD.
format Online
Article
Text
id pubmed-8549666
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-85496662021-10-29 Prevalence of iatrogenic atrial septal defects (iASD) after mitral valve (MV) transcatheter edge-to-edge repair (TEER) in the long-term follow-up Paukovitsch, Michael Schneider, Leonhard Moritz Reichart, Christine Nita, Nicoleta Rottbauer, Wolfgang Keßler, Mirjam Markovic, Sinisa Open Heart Interventional Cardiology OBJECTIVES: To investigate prevalence of iatrogenic atrial septal defects (iASDs) after mitral valve (MV) transcatheter edge-to-edge repair (TEER) with the MitraClip in the long-term follow-up. BACKGROUND: MV TEER requires transseptal puncture using a large 22 F sheath. Prevalence, impact and haemodynamic effects of these iASDs remain unknown in the long-term follow-up. METHODS: This prospective study enrolled patients who had undergone first-time TEER at our university hospital between January 2017 and June 2018 for a clinical long-term follow-up study. Prevalence of iASD was investigated 12 months post-TEER using transoesophageal echocardiography (TEE). Study protocol further consisted of transthoracic echocardiography (TTE) and exercise testing. Incidence of all-cause death was compared 12 months post-TEE follow-up. This study was approved by local ethics committee. RESULTS: 48 patients participated in clinical follow-up examinations. Median time between TEER and clinical follow-up examination (TEE, TTE, exercise testing) was 19.5 (IQR: 7.0) months after TEER. Persistent iASD was found in 41.7% of patients. TEER was found to be equally effective in reducing MR and clinical symptoms in both groups at baseline as well as follow-up. Procedural fluoroscopy and device times were significantly longer in the iASD group. MR reduction and functional status (New York Heart Association Class, 6 Minute Walking Test distance) were similar in both groups. Nevertheless, a significant decrease in systolic pulmonary artery pressure (sPAP) and significantly smaller atrial diameters were observed in patients with iASD at follow-up. CONCLUSION: Prevalence of iASDs after TEER in long-term follow-up was about 41%. Although a significant reduction of sPAP and better left atrial reverse remodelling were accomplished in patients with iASD, clinical impact appears low. Manipulation at the atrial septum might play a key role in creating persisting iASD. BMJ Publishing Group 2021-10-26 /pmc/articles/PMC8549666/ /pubmed/34702777 http://dx.doi.org/10.1136/openhrt-2021-001732 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Interventional Cardiology
Paukovitsch, Michael
Schneider, Leonhard Moritz
Reichart, Christine
Nita, Nicoleta
Rottbauer, Wolfgang
Keßler, Mirjam
Markovic, Sinisa
Prevalence of iatrogenic atrial septal defects (iASD) after mitral valve (MV) transcatheter edge-to-edge repair (TEER) in the long-term follow-up
title Prevalence of iatrogenic atrial septal defects (iASD) after mitral valve (MV) transcatheter edge-to-edge repair (TEER) in the long-term follow-up
title_full Prevalence of iatrogenic atrial septal defects (iASD) after mitral valve (MV) transcatheter edge-to-edge repair (TEER) in the long-term follow-up
title_fullStr Prevalence of iatrogenic atrial septal defects (iASD) after mitral valve (MV) transcatheter edge-to-edge repair (TEER) in the long-term follow-up
title_full_unstemmed Prevalence of iatrogenic atrial septal defects (iASD) after mitral valve (MV) transcatheter edge-to-edge repair (TEER) in the long-term follow-up
title_short Prevalence of iatrogenic atrial septal defects (iASD) after mitral valve (MV) transcatheter edge-to-edge repair (TEER) in the long-term follow-up
title_sort prevalence of iatrogenic atrial septal defects (iasd) after mitral valve (mv) transcatheter edge-to-edge repair (teer) in the long-term follow-up
topic Interventional Cardiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8549666/
https://www.ncbi.nlm.nih.gov/pubmed/34702777
http://dx.doi.org/10.1136/openhrt-2021-001732
work_keys_str_mv AT paukovitschmichael prevalenceofiatrogenicatrialseptaldefectsiasdaftermitralvalvemvtranscatheteredgetoedgerepairteerinthelongtermfollowup
AT schneiderleonhardmoritz prevalenceofiatrogenicatrialseptaldefectsiasdaftermitralvalvemvtranscatheteredgetoedgerepairteerinthelongtermfollowup
AT reichartchristine prevalenceofiatrogenicatrialseptaldefectsiasdaftermitralvalvemvtranscatheteredgetoedgerepairteerinthelongtermfollowup
AT nitanicoleta prevalenceofiatrogenicatrialseptaldefectsiasdaftermitralvalvemvtranscatheteredgetoedgerepairteerinthelongtermfollowup
AT rottbauerwolfgang prevalenceofiatrogenicatrialseptaldefectsiasdaftermitralvalvemvtranscatheteredgetoedgerepairteerinthelongtermfollowup
AT keßlermirjam prevalenceofiatrogenicatrialseptaldefectsiasdaftermitralvalvemvtranscatheteredgetoedgerepairteerinthelongtermfollowup
AT markovicsinisa prevalenceofiatrogenicatrialseptaldefectsiasdaftermitralvalvemvtranscatheteredgetoedgerepairteerinthelongtermfollowup